We are passionate about our purpose, we are committed to each other and we act as one team with a heightened sense of urgency. We plan to employ our validated TPE® technology to expand our pipeline of oral therapeutic options for patients with rare diseases to use in place of painful and burdensome injections.
We never give up. Resiliency is in our DNA.
We love what we do, and we achieve results that matter for patients, for investors and for ourselves.
We are clever and resourceful in how we identify and execute on meaningful opportunities.
Our commitment to patients is unwavering. The only way we can succeed is to be committed to each other in achieving our purpose.
Diseases progress and our patients cannot wait. This is what drives every activity within our organization to bring innovations to market as fast as we can.
We leverage our resiliency in the face of challenges to pursue our mission.
Passion for Results
We embed integrity and energy in all we do to achieve superior results built on a foundation for sustainable and profitable growth.
We utilize our innovative technology to develop novel solutions that address significant unmet medical needs.
Commitment to People
We focus on the impact of our actions and are responsible to patients, our community and our people.
Sense of Urgency
We act with speed, efficiency and accountability to benefit patients, employees, and shareholders.
Chiasma’s team has the development and commercialization expertise needed to bring novel oral therapies to patients with rare diseases to overcome their everyday challenges associated with existing injectables.